Victory Park Funds Newly Launched Enteris BioPharma
Victory Park Capital announced it has funded newly-launched portfolio company Enteris BioPharma, a maker of oral delivery peptides and small molecule therapeutics.
August 14, 2013
Enteris BioPharma | Victory Park Capital
ABF Journal